Get started
Author

Frances Sarah Barnett

Observed names: F. Barnett, Frances BARNETT, Frances Barnett, Frances Barnett (13354740), Frances S. Barnett
Observed institutions: The Royal Melbourne Hospital, Northern Health, Northern Hospital, Footscray Hospital, Ludwig Cancer Research, Western Hospital, RMIT University
ORCID: 0000-0002-5897-0806
Observed ORCID: 0000-0002-5897-0806
OpenAlex ID: A5059673131
Patient Age and Comorbidity Are Major Determinants of Adjuvant Chemotherapy Use for Stage III Colon Cancer in Routine Clinical Practice
2008 · Sumitra Ananda, Kathryn M. Field, et al. · Journal of Clinical Oncology · 39
Quality of Pathology Reporting Impacts on Lymph Node Yield in Colon Cancer
2007 · Nicholas A. Rieger, Frances S. Barnett, et al. · Journal of Clinical Oncology · 37
PDF
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer
2023 · Matthew Loft, Sheau Wen Lok, et al. · Breast Cancer Research and Treatment · 13
Syndrome of inappropriate anti‐diuretic hormone secretion secondary to carboplatin after docetaxel‐carboplatin‐trastuzumab combination for early stage HER‐2 positive breast cancer
2012 · Natalie TURNER, Josephine STEWART, et al. · Asia-Pacific Journal of Clinical Oncology · 12
Telehealth in cancer care during the COVID-19 pandemic
2022 · Kate Burbury, Peter Brooks, et al. · Journal of Telemedicine and Telecare · 11
Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer
2020 · Yada Kanjanapan, Sheau Wen Lok, et al. · Breast Cancer Research and Treatment · 5
Addressing disparities in health outcomes for patients with advanced pancreatic cancer and limited English proficiency
2024 · Colin Williams, Geoff Chong, et al. · Asia-Pacific Journal of Clinical Oncology · 4
Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study
2022 · Iris Tung, Cristina Moldovan, et al. · Clinical Breast Cancer · 3
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer.
2020 · Matthew Loft, Sheau Wen Lok, et al. · Journal of Clinical Oncology · 3
Adjuvant chemotherapy for stage II and stage III colon cancer—What is happening in routine practice?
2009 · S. Ananda, S. Kosmider, et al. · Journal of Clinical Oncology · 3
Re: Residual Treatment Disparities After Oncology Referral for Rectal Cancer
2008 · Kathryn M. Field, Suzanne Kosmider, et al. · JNCI Journal of the National Cancer Institute · 3
51P Real world outcomes in elderly women with HER2-positive advanced breast cancer
2020 · N. Evans, A. Anton, et al. · Annals of Oncology · 2
Inflammatory breast cancer and secondary Pure Red Cell Aplasia
2011 · Samuel J. Harris, Jo-An A. Seah, et al. · Acta Oncologica · 2
PDF
Immune checkpoint therapy in colorectal cancer: is first better than last?
2023 · Yui Kaneko, Zainab Naseem, et al. · Annals of Coloproctology · 1
PDF
Abstract PS6-35: Real world outcomes in elderly women with HER2 positive advanced breast cancer
2021 · Nicole Evans, Angelyn Anton, et al. · Cancer Research · 1
Real‐World Toxicity and Outcomes of KEYNOTE‐522‐Style Neoadjuvant Pembrolizumab for Triple‐Negative Breast Cancer in Australia
2026 · Evon Jude, Sarah Jaboury, et al. · Asia-Pacific Journal of Clinical Oncology
PDF
Timeliness of Care and Treatment Patterns for Pancreatic Cancer in Victoria, Australia: Comparison With Optimal Care Pathways Targets
2026 · Sam Banks, Belinda Lee, et al. · ANZ Journal of Surgery
PDF
Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic cancer: an analysis of PURPLE real-world registry data from an Australian population
2025 · Emma Sanderson, Belinda Lee, et al. · BMC Public Health
PDF
Abstract P3-10-12: Retrospective analysis of adverse events and outcomes of patients receiving neoadjuvant pembrolizumab for triple negative breast cancer in Australia
2025 · Evon Jude, Jasmine Grisold, et al. · Clinical Cancer Research
Uptake of bone‐modifying agents in patients with HER2+ metastatic breast cancer with bone metastases – prospective data from a multi‐site Australian registry
2021 · Vanessa Wong, Richard de Boer, et al. · Internal Medicine Journal
Improving the Physical Activity of Breast Cancer Survivors Through Fitness Trackers
2021 · C. Lynch, S. Bird, et al. · Studies in health technology and informatics
PDF
Abstract P1-18-13: Impact of prior (neo)adjuvant trastuzumab exposure on the efficacy of HER2 targeted therapy for metastatic breast cancer
2020 · Yada Kanjanapan, Dan Tran, et al. · Cancer Research
Use and impact of perioperative chemotherapy in patients with resectable colorectal cancer metastases.
2020 · Amy Body, Margaret Lee, et al. · Journal of Clinical Oncology
Use and impact of perioperative chemotherapy in patients with resected colorectal cancer metastases
2019 · Amy Body, Margaret Lee, et al. · Asia-Pacific Journal of Clinical Oncology
Individual perceptions of physical activity in a community-level initiative in North Queensland, Australia
2016 · Scott D. Gayton, Maria Aparecida Caltabiano, et al. · ResearchOnline - JCU (James Cook University)
PDF
Works count: 32
Citation count: 140
H-index: 5
I10-index: 5
Year
Topic
Type